| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Appendicectomy: a novel treatment for ulcerative colitis?
|
Ukashi, Offir
|
|
|
10 |
6 |
p. 497-498
|
artikel
|
| 2 |
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial
|
|
|
|
10 |
6 |
p. 550-561
|
artikel
|
| 3 |
Breaking the cycle: time to invest in IBS
|
The Lancet Gastroenterology & Hepatology,
|
|
|
10 |
6 |
p. 491
|
artikel
|
| 4 |
Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis
|
Cuffe, Melanie S
|
|
|
10 |
6 |
p. 520-536
|
artikel
|
| 5 |
Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis
|
Khasawneh, Mais
|
|
|
10 |
6 |
p. 537-549
|
artikel
|
| 6 |
Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
|
Teoh, Anthony Yuen Bun
|
|
|
10 |
6 |
p. e8-e16
|
artikel
|
| 7 |
Expanding the menu of dietary therapies in irritable bowel syndrome
|
Shin, Andrea
|
|
|
10 |
6 |
p. 493-495
|
artikel
|
| 8 |
Gut–brain neuromodulators for IBS: what's in a name?
|
Masclee, Adrian A M
|
|
|
10 |
6 |
p. 495-497
|
artikel
|
| 9 |
Inclusion of patients with isolated ulcerative proctitis in clinical trials
|
Nguyen, Andrew W
|
|
|
10 |
6 |
p. 504
|
artikel
|
| 10 |
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
|
Panaccione, Remo
|
|
|
10 |
6 |
p. 507-519
|
artikel
|
| 11 |
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
|
Gani, Cihan
|
|
|
10 |
6 |
p. 562-572
|
artikel
|
| 12 |
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design
|
Honap, Sailish
|
|
|
10 |
6 |
p. 593-604
|
artikel
|
| 13 |
Research in Brief
|
Baker, Holly
|
|
|
10 |
6 |
p. 506
|
artikel
|
| 14 |
Retraction and republication—Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
|
The Editors of The Lancet Gastroenterology & Hepatology,
|
|
|
10 |
6 |
p. 502-503
|
artikel
|
| 15 |
The intestinal barrier: a pivotal role in health, inflammation, and cancer
|
Neurath, Markus F
|
|
|
10 |
6 |
p. 573-592
|
artikel
|
| 16 |
The pitfalls and promises of scoping reviews in gastroenterology literature
|
Gordon, Morris
|
|
|
10 |
6 |
p. 504-505
|
artikel
|
| 17 |
The pitfalls and promises of scoping reviews in gastroenterology literature – Authors’ reply
|
Levinson, Carrie
|
|
|
10 |
6 |
p. 505
|
artikel
|
| 18 |
The urgent need for implementation science to achieve hepatitis C elimination
|
Fontaine, Guillaume
|
|
|
10 |
6 |
p. 498-502
|
artikel
|
| 19 |
U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis
|
Noor, Nurulamin M
|
|
|
10 |
6 |
p. 492-493
|
artikel
|
Tijdschrift beschrijving